Success Metrics

Clinical Success Rate
57.1%

Based on 4 completed trials

Completion Rate
57%(4/7)
Active Trials
0(0%)
Results Posted
75%(3 trials)
Terminated
3(30%)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_2
3
30%
Ph phase_4
4
40%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

4 of 8 finished

Non-Completion Rate

50.0%

4 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(4)
Terminated(4)
Other(2)

Detailed Status

Completed4
Terminated3
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
57.1%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (30.0%)
Phase 31 (10.0%)
Phase 44 (40.0%)
N/A2 (20.0%)

Trials by Status

withdrawn110%
terminated330%
unknown220%
completed440%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10